Difference between revisions of "Envelope glycoprotein gp120"
m (Gp120 moved to Envelope glycoprotein gp120) |
|||
| Line 35: | Line 35: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/ | + | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1gc1.pdf ASAView] pdf |
| + | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1gc1.txt ASAView txt | ||
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Revision as of 08:01, 25 July 2007
| Template:Infobox header| Envelope glycoprotein gp120 | |
|---|---|
| Envelope glycoprotein gp120 | |
| Substrate peptide name | Envelope glycoprotein gp120 |
| Synonyms | gp120 |
| Determination type | In vitro |
| Source | HIV |
| Subcellular localization | HIV exterior membrane |
| Swissprot ID | P03378 |
| Reactive glutamines | Q265 |
| Reactive lysines | Not determined yet |
| Substrate sequence | |
| Structure | 1GC1 |
| Surface accessibility | ASAView pdf
[http://gibk21.bse.kyutech.ac.jp/asaview/all/1gc1.txt ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:8104907 |
| Notes | |
| Template:Infobox header | | |
